Search

everythinglearnresearchcommunity

for

Search:↓

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Minoxidil works in liver and outer hair root sheath for hair growth.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Finasteride reduces hair growth and is safe for women with excessive hair.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Minoxidil effectively treats hair loss, works better for women, and requires consistent use.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Method accurately measures finasteride concentration in medicine.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Finasteride and metformin both help treat PCOS, but using them together works best.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.